Oct. 29, 2026 — Instylla, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved the expanded indication for the Embrace Hydrogel Embolic System (HES) to include embolization ...
Embolization devices
Emoblization devices allow the occlusion of selective blood vessels by introducing emboli.
Oct. 29, 2026 — Instylla, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved the expanded ...
Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...
June 8, 2026 – Embolization, Inc. will present its novel embolization coil, using proprietary shape-memory biocompatible ...
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ...
July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...
March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...
Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and ...
June 29, 2018 — Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next ...
October 16, 2017 — Medtronic announced the launch of the Concerto 3-D Detachable Coil System at the Cardiovascular and ...
February 24, 2016 — ArtVentive Medical Group Inc. announced enrollment in the ongoing ArtVentive EOS Endoluminal ...
January 14, 2016 — Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary ...
December 17, 2015 — ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive ...
November 03, 2026